Nutriband jumps after news of manufacturing agreement

Nutriband

12/10/2021 18:19

** Shares in Nutriband Inc  NTRB.O , which is developing
transdermal pharmaceutical products, were up 36.9% at $10.13
after rising as high as $11.72
    ** Trading volume at record level, with about 50 mln shares
changed hands so far vs float of 4.6 mln, according to Refinitiv
    ** NTRB, previously trading as a pink sheets company,
announced on Oct. 1 that it had switched to trade on the Nasdaq
capital market that day 
    ** NTRB announced https://finance.yahoo.com/news/nutriband-inc-signs-exclusive-manufacturing-113000846.html
 on Tues it signed exclusive
manufacturing agreement with San Diego-based Diomics for
Diocheck product, for individuals wanting to monitor presence of
antibodies to COVID-19 over extended period of time.  urn:newsml:reuters.com:*:nACSWWjf9a
    ** For its fiscal year 2022, set to end in January, the one
analyst who covers NTRB sees it reporting a profit of $0.03/shr
on revenue of $1.4 mln, according to Refinitiv

 (Reporting By Sinéad Carew)
 ((sinead.carew@thomsonreuters.com; +1 (646) 223 6186; Reuters
Messaging: sinead.carew.thomsonreuters.com@reuters.net))